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Reprogramming of intracellular metabolism is common in activated immune cells. In this issue ofCell Metab-
olism, Haschemi et al. (2012) show that the sedoheptulose kinase CARKL is required for metabolic reprog-
ramming in activated macrophages and provide evidence that changes in glucose metabolism and the
pentose phosphate pathway (PPP) influences macrophage polarization.Cells of the innate immune system,
including macrophages and dendritic
cells (DCs), identify foreign invaders
through recognition of pathogen-associ-
ated molecular patterns (PAMPs), such
as lipopolysaccharide (LPS) (Serbina
et al., 2008). The environmental milieu of
infection dictates the differentiation of
immune cells toward lineages specifically
tailored to control the infecting pathogen.
Macrophages, for example, differentiate
toward an inflammatory ‘‘M1’’ lineage or
an immunomodulatory ‘‘M2’’ lineage
(Figure 1). During activation, immune cells
switch from a quiescent to an activated
state characterized by increased meta-
bolic activity and new effector functions
(Jones and Thompson, 2007). Recent
evidence suggests that immune cells
adopt specific metabolic signatures
required for proper effector function
(Michalek et al., 2011). An important ques-
tion in the field of ‘‘immunometabolism’’ is
whether metabolic pathways themselves
can alter immune cell differentiation and
thus direct effector function. Haschemi
et al. (2012) present evidence that the
carbohydrate kinase-like (CARKL) protein
plays a key role in regulating macrophage
metabolism and can influence macro-
phage polarization.Macrophages play an important role
in inflammatory responses, but the meta-
bolic pathways engaged in macrophages
have not been well characterized.
Haschemi and colleagues conducted an
overexpression screen of protein and
nonprotein kinases to identify novel medi-
ators of LPS-stimulated TNFa production
by macrophages (Haschemi et al., 2012).
One interesting finding was the identifica-
tion of several kinases involved in glucose
metabolism that also scored as immuno-
modulatory kinases in macrophages.
The authors focused their attention on
CARKL (Wamelink et al., 2008), a carbohy-
drate kinase whose substrate is sedohep-
tulose, a 7-carbon sugar produced by
plants with structural similarity to
fructose. The authors demonstrate in
the current work that CARKL catalyzes
the production of sedoheptulose-7-
phosphate (S7P), an intermediate of
the pentose phosphate pathway (PPP).
Using a series of overexpression and
knockdown approaches, the authors
demonstrated that LPS-induced cytokine
production is influenced by CARKL
activity. When ectopically expressed in
macrophages and macrophage cell lines,
CARKL antagonized LPS-induced pro-
duction of NF-kB-regulated cytokines(i.e., TNFa and IL-6), which correlated
with lower NF-kB luciferase reporter
activity. Notably, the effects of CARKL
on NF-kB activity were modest, suggest-
ing the existence of alternative pathways
controlled by CARKL activity that could
influence cytokine production.
The negative effect ofCARKLactivity on
M1macrophage function raised thepossi-
bility that changes in glucose metabolism
may influence the inflammatory properties
of M1 macrophages. A metabolic transi-
tion toward aerobic glycolysis reminiscent
of the Warburg effect occurs in LPS-
stimulated DCs (Krawczyk et al., 2010),
indicating that proinflammatory stimuli
can skew cellular metabolism toward
glycolysis.Using respirometry andmetab-
olomics techniques, Haschemi et al.
(2012) demonstrated that LPS-induced
M1 macrophages also displayed in-
creased glycolysis and decreased oxygen
consumption (oxygen consumption rate,
OCR). This contrasted sharply with
IL-4-polarized M2-like macrophages,
whose metabolic profile was similar to
unpolarized macrophages. Using asym-
metrically labeled 13C-1,2-glucose for
metabolic tracing experiments, Haschemi
et al. (2012) demonstrated that LPS
promoted the flow of glucose through15, June 6, 2012 ª2012 Elsevier Inc. 793
Figure 1. Metabolic Reprogramming during Macrophage Polarization
Macrophages differentiate toward an inflammatory ‘‘M1’’ lineage in response to LPS stimulation (classically activated), while IL-4 and IL-13 promote the alternate
activation of macrophages toward a suppressive ‘‘M2’’ lineage. M1-polarized macrophages generate a panel of inflammatory cytokines (TNFa, IL-12, IL-6) that
potentiate inflammatory T cell differentiation, while alternatively activated macrophages express higher levels of scavenger receptors and immunomodulatory
cytokines (IL-10, TGFb). LPS stimulation has dual effects on NF-kB-mediated cytokine production and a reduction of CARKL expression. Reduced CARKL
expression in M1 macrophages is associated with greater flux through glycolysis and the oxidative pentose phosphate pathway (Ox-PPP) to increase overall
redox potential (NADH:NAD+, GSH:GSSG) and a reduced oxygen consumption rate (OCR). In IL-4 stimulated M2-like cells CARKL maintains sedoheptulose-
7-phosphate (S7P) levels, reducing flow through the PPP, and maintaining glycolysis and OCR. CARKL, carbohydrate kinase-like; G6P, glucose-6-phosphate;
F6P, fructose-6-phosphate; G3P, glyceraldehyde-3-phosphate; Ru5P, ribuose-5-phosphate; R5P, ribose-5-phosphate; X5P, xyulose-5-phosphate; S7P, sedo-
heptulose-7-phosphate.
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Previewsboth the glycolytic pathway and the PPP,
leading to significant production of
ribose-5-phosphate (R5P), xylulose-5-
phosphate (X5P), and sedoheptulose-
7-phosphate (S7P)—the product of
CARKL—from glucose (Figure 1). Ha-
schemi and colleagues next examined
the effects of manipulating CARKL
expression on macrophage metabolism
(Haschemi et al., 2012). Constitutive
expression of CARKL in primary macro-
phages and macrophage cell lines
decreased glycolytic flux upon LPS stimu-
lation while simultaneously increasing
OCR, mimicking the metabolic profile of
M2-like cells. Conversely, ablation of
CARKL expression by RNAi (miCARKL)
primed macrophages to adopt an
M1-like metabolic state prior to LPS
stimulation, marked by increased glycol-
ysis and reduced OCR. Overexpression794 Cell Metabolism 15, June 6, 2012 ª2012and knockdown of CARKL respectively
reduced and increased flow of glycolytic
intermediates into the oxidative arm of
the PPP by controlling S7P levels. These
results suggest that the regulation of
S7P levels by CARKL functions as a
rate-limiting step for balancing metabolic
intermediates of the nonoxidative PPP
and glycolysis (Figure 1), although more
work is needed to establish a clear
mechanism.
Why is a ‘‘glycolysis-PPP’’ axis such
a focal point for M1macrophage polariza-
tion? One consequence of elevated PPP
flux is the maintenance of a high cellular
redox state. Two important metabolites
generated by oxidative PPP activity
are NADPH and ribulose-5-phosphate
(Ru5P) (Figure 1). If the cellular need for
NADPH exceeds nucleotide biosynthesis,
Ru5P passes into the nonoxidative arm ofElsevier Inc.the PPP to generate F6P and G3P, which
re-enter glycolysis. M1 macrophages
drive several processes that require
a high amount of NADPH, notably the
NADPH oxidase-dependent respiratory
burst (Rybicka et al., 2010) and gluta-
thione biosynthesis to buffer reactive
oxygen species (ROS). Ectopic expres-
sion of CARKL reduces oxidative PPP
flux and promotes an oxidative state
(increased GSSG and NAD+) character-
istic of M2-like polarization. Not surpris-
ingly, CARKL-expressing cells display
defects in LPS-induced superoxide
production. CARKL is rapidly downregu-
lated upon LPS stimulation, suggesting
that suppression of CARKL activity and
differential metabolism of S7P may help
to refocus macrophage metabolism to
favor increased PPP activity and a high
redox state to support M1 polarization.
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PreviewsThe work of Haschemi et al. (2012)
provides further evidence of differential
metabolic reprogramming of immune
cells in response to differentiation signals.
These results raise the key question of
whether the metabolic changes in macro-
phages simply reflect a general response
to microbial stimuli or whether metabolic
flux directly influences cellular differentia-
tion programs to shape inflammatory
immune responses. If the latter is true
and metabolic patterning can direct
lineage specification, then how may this
phenomenon occur? Many transcription
factors including NF-kB contain redox-
sensitive Cys residues (Nishi et al., 2002)
and can be influenced by the cellular
redox state. Maintenance of a high
NADH:NAD+ ratio induced by LPS stimu-
lation (and suppressed by CARKL) may
enhance NF-kB binding activity and favor
M1 macrophage differentiation. Another
possibility is that changes in metabolic
flux may influence epigenetic imprinting.
Recent work has shown that metabolicenzymes can affect histone acetylation
and demethylation activity (Lu et al.,
2012; Wellen et al., 2009), which may
impact cell-differentiation programs. It is
unclear whether S7P possesses signaling
properties beyond its role as a PPP
intermediate. Further exploration of how
signal-transduction pathways down-
stream of immune and cytokine receptors
influence cellular metabolism may help us
understand how metabolism may impact
cellular differentiation and effector func-
tion in the immune system.REFERENCES
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The ChREBP transcription factor is regulated by glucose and plays a role in insulin sensitivity, but the mech-
anism underlying these effects remains unclear. In a recent Nature article, Herman et al. (2012) show that
a shorter ChREBP isoform (ChREBP-b) links glucose transport to lipogenesis in white adipose tissue.The quest for the molecular factor medi-
ating the transcriptional effects of glucose
remained unfruitful until ChREBP (carbo-
hydrate responsive element binding
protein) was cloned in 2001 (Yamashita
et al., 2001). Glucose modifies ChREBP
at the posttranslational level (Bricambert
et al., 2010; Guinez et al., 2011) and stim-
ulates its nuclear translocation, therebypromoting binding to a ChREBP binding
site (ChoRE) present on its target genes,
which include glycolytic and lipogenic
genes. The relationship of ChREBP with
insulin resistance is complex: whereas
its inhibition in liver of obese mice
counteracts fatty liver and systemic insulin
resistance (Dentin et al., 2006), ChREBP
overexpression, by modifying hepaticfatty acid composition, promotes a state
of hepatic steatosis that is dissociated
from insulin resistance (Benhamed et al.,
2012). Furthermore, ChREBP is also ex-
pressed in white adipose tissue (WAT),
a target site of insulin resistance in
obesity-related diseases. Decreased
glucose transport and metabolism in
adipocytes together with alterations in15, June 6, 2012 ª2012 Elsevier Inc. 795
